Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

DSIP 5 mg: research material

Buy DSIP 5 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

DSIP stands for delta sleep-inducing peptide. It is a nonapeptide, meaning it contains nine amino-acid residues, used in experimental neurophysiology research.

Choose the material and presentation

The reference sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, abbreviated WAGGDASGE. Sequence variants and modified analogues are separate materials. This product is supplied as dry powder, not as a prepared nasal spray or a sleep medication.

Other presentations: DSIP 10 mg.

DSIP research: the measured endpoint matters

The original characterization compared synthetic DSIP with related peptides in blinded rabbit experiments and reported changes in EEG activity. EEG records electrical activity; that endpoint needs to be distinguished from a broad claim about sleep quality.

A later blinded rabbit study, using a different administration method and slow-sleep assessment, found no statistically significant difference from its comparison conditions. These studies illustrate why the name alone cannot establish a reliable effect across models. Neither is evidence that this product treats human insomnia.

Study 1 · Study 2

Product records and batch reports

Open the COA and documents tab for the available batch reports and product files. Match the product and lot, then read identity, purity and measured content as separate results.

Additional information

CAS No.

62568-57-4

Purity

≥99%

Sequence

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

Molecular Formula

C35H48N10O15

Molecular Weight

848.81 g/mol

Applications

Sleep modulation studies, stress regulation research, neuroprotection investigations, analgesia models

Synthesis

Solid-phase synthesis

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

COA & Documents

Independent lot testing

DSIP 5mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
78142
Report number
IF-824-QSA-TR006-2026-127-17
Date tested
March 2, 2026
Reported purity
99.9%
Labeled content
5 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for DSIP 5mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support